Welcome to our dedicated page for Flora Growth news (Ticker: FLGC), a resource for investors and traders seeking the latest updates and insights on Flora Growth stock.
Flora Growth Corp (FLGC) operates at the intersection of cannabis cultivation and pharmaceutical distribution, maintaining a vertically integrated model across 15+ countries. This page delivers essential updates about corporate milestones, regulatory compliance, and market expansion efforts.
Investors and industry observers will find comprehensive coverage of earnings reports, strategic partnerships, product launches, and operational developments. Our aggregation ensures you stay informed about FLGC’s commercial wholesale activities, consumer brand portfolio, and pharmaceutical-grade medical solutions.
Key updates include international supply chain advancements, CBD product innovations, and compliance achievements in regulated markets. Bookmark this page for real-time access to Flora Growth’s press releases and third-party analysis, curated to support informed decision-making.
Flora Growth Corp. (NASDAQ: FLGC) has announced a three-month extension on the expiry dates of approximately 6.67 million common share purchase warrants. Originally set to expire 18 months post-issuance, the new expiry dates now range from October 25, 2021, to October 20, 2022. The exercise price remains unchanged at US$3.00 per share. This extension applies to all unexercised warrants issued during the Regulation A+ Tier 2 offering in December 2020. Flora aims to enhance its market positioning as a leading outdoor cultivator and manufacturer of cannabis-derived products.
Flora Growth Corp. (NASDAQ: FLGC) plans to relocate its headquarters to Miami, Florida by Q1 2022, following an extensive review process. The new office will be significantly larger than its current space in Toronto, designed to support growth and attract talent. Miami's Brickell financial district was chosen for its favorable business climate, logistics, and talent pool. Flora aims to create a collaborative workspace with advanced technology features. The company continues to operate an administrative office in Toronto.
Flora Growth Corp. (NASDAQ: FLGC) has launched its premium beauty brand, Ô (Awe), designed by beauty influencer Paulina Vega. This brand targets the prestige market and focuses on customized consumer experiences. Initial sales will occur via an e-commerce platform, with plans for retail availability by Q4 2021. The product line includes anti-aging creams and pH-balanced cleansers, utilizing naturally sourced CBD. Flora Beauty emphasizes social responsibility and ingredient transparency. The brand will promote its offerings at the Cosmoprof North America event from August 29-31, 2021.
Flora Growth Corp (NASDAQ: FLGC) is hosting a live fireside chat on July 15 at 1:00 pm ET, featuring CEO Luis Merchan, CRO Jason Warnock, and lead scientific advisor Dr. Annabelle Manalo-Morgan. The discussion will cover updates on Cosechemos and Flora Lab, highlighting their roles in international expansion and revenue growth. Additionally, it will touch upon the company's holistic consumer packaged goods strategy and advancements in cannabinoid research, focusing on the potential benefits for medical patients and legislative developments in the U.S.
Flora Growth Corp. (NASDAQ: FLGC) has appointed Brigitte Baptiste as a strategic advisor to enhance its research and development in sustainable cannabis practices. Alongside EAN University, Baptiste will focus on cannabis supply chain studies, examining areas such as carbon footprint and energy output. This initiative aims to foster sustainable entrepreneurship among students while advancing Flora's premium brand portfolio. CEO Luis Merchan highlighted the growing demand for sustainable products and the company’s plans to scale its operations across various sectors, leveraging cost-effective organic biomass.
Flora Growth Corp (NASDAQ: FLGC) will host a virtual fireside chat on June 24, 2021, at 1:00 PM ET, featuring CEO Luis Merchan and VP James Williams. The discussion will cover recent strategic announcements related to Hoshi and Koch & Gsell, emphasizing their significance for international expansion and expected revenue contributions. Additionally, Roger Koch, CEO of Koch & Gsell, will outline the Heimat product portfolio and international plans. Flora aims to leverage its outdoor cultivation practices to provide high-quality cannabis derivatives across various sectors.
Flora Growth Corp. (NASDAQ: FLGC) has appointed Dr. Annabelle Manalo-Morgan as the Lead Scientific Advisor to enhance research and development in cannabis-based therapies. Dr. Annabelle will head a science advisory team focused on the therapeutic application of cannabinoids, aiming to produce scientifically-backed cannabis products. The appointment is part of Flora's strategy to bolster its medical divisions and expedite growth initiatives. Flora plans to activate clinical trials following the establishment of necessary protocols, reinforcing its commitment to innovation and patient education.
Flora Growth Corp. (NASDAQ: FLGC) has agreed to acquire 100% of Koch & Gsell for CHF 20 million (approximately US$22.2M), to enhance its CPG portfolio with the Heimat brand, known for hemp products and trailing revenues of US$7.6M. The acquisition aims to boost distribution in Europe and Asia while leveraging proprietary manufacturing technology, producing over 40,000 packs of cigarettes daily. Following the deal, Flora plans to invest CHF 2 million (US$2.2M) to expand the Heimat brand. CEO Roger Koch will continue leading Koch & Gsell post-acquisition.
Flora Growth Corp. (NASDAQ: FLGC) announces the appointment of Jason Warnock as Chief Revenue Officer and Lee Leiderman as Chief Financial Officer. The changes aim to enhance the company's growth and commercialization phase. Warnock brings over 20 years of sales leadership, focusing on sustainable revenue growth. Leiderman has extensive financial management experience from firms like PricewaterhouseCoopers and Philip Morris. The new executives are expected to drive global growth and optimize recent acquisitions, positioning Flora to capture market opportunities in the cannabis sector.
FAQ
What is the current stock price of Flora Growth (FLGC)?
What is the market cap of Flora Growth (FLGC)?
